185 related articles for article (PubMed ID: 9419966)
1. Proliferation of human malignant astrocytomas is dependent on Ras activation.
Guha A; Feldkamp MM; Lau N; Boss G; Pawson A
Oncogene; 1997 Dec; 15(23):2755-65. PubMed ID: 9419966
[TBL] [Abstract][Full Text] [Related]
2. Isotype-specific Ras.GTP-levels predict the efficacy of farnesyl transferase inhibitors against human astrocytomas regardless of Ras mutational status.
Feldkamp MM; Lau N; Roncari L; Guha A
Cancer Res; 2001 Jun; 61(11):4425-31. PubMed ID: 11389071
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.
Feldkamp MM; Lau N; Guha A
Oncogene; 1999 Dec; 18(52):7514-26. PubMed ID: 10602510
[TBL] [Abstract][Full Text] [Related]
4. Ras activation in astrocytomas and neurofibromas.
Guha A
Can J Neurol Sci; 1998 Nov; 25(4):267-81. PubMed ID: 9827227
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of activated Ki-Ras does not constitutively activate the mitogen-activated protein kinase pathway but attenuates epidermal growth factor receptor activation in human astrocytoma cells.
Luo W; Sharif M
Int J Oncol; 1999 Jan; 14(1):53-62. PubMed ID: 9863009
[TBL] [Abstract][Full Text] [Related]
6. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras.
Feldkamp MM; Lau N; Rak J; Kerbel RS; Guha A
Int J Cancer; 1999 Mar; 81(1):118-24. PubMed ID: 10077162
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo growth inhibition of human malignant astrocytoma cells by the farnesyltransferase inhibitor B1620.
Kurimoto M; Hirashima Y; Hamada H; Kamiyama H; Nagai S; Hayashi N; Endo S
J Neurooncol; 2003 Jan; 61(2):103-12. PubMed ID: 12622448
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.
Reardon DB; Contessa JN; Mikkelsen RB; Valerie K; Amir C; Dent P; Schmidt-Ullrich RK
Oncogene; 1999 Aug; 18(33):4756-66. PubMed ID: 10467423
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FAK promotes Ras activity through the formation of a FAK/p120RasGAP complex in malignant astrocytoma cells.
Hecker TP; Ding Q; Rege TA; Hanks SK; Gladson CL
Oncogene; 2004 May; 23(22):3962-71. PubMed ID: 15077193
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model.
Ding H; Shannon P; Lau N; Wu X; Roncari L; Baldwin RL; Takebayashi H; Nagy A; Gutmann DH; Guha A
Cancer Res; 2003 Mar; 63(5):1106-13. PubMed ID: 12615729
[TBL] [Abstract][Full Text] [Related]
11. Growth factor-independent proliferation of erythroid cells infected with Friend spleen focus-forming virus is protein kinase C dependent but does not require Ras-GTP.
Muszynski KW; Thompson D; Hanson C; Lyons R; Spadaccini A; Ruscetti SK
J Virol; 2000 Sep; 74(18):8444-51. PubMed ID: 10954544
[TBL] [Abstract][Full Text] [Related]
12. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in Fc epsilonRI-mediated signaling.
Graham TE; Pfeiffer JR; Lee RJ; Kusewitt DF; Martinez AM; Foutz T; Wilson BS; Oliver JM
J Immunol; 1998 Dec; 161(12):6733-44. PubMed ID: 9862703
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples.
Hecker TP; Grammer JR; Gillespie GY; Stewart J; Gladson CL
Cancer Res; 2002 May; 62(9):2699-707. PubMed ID: 11980671
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
[TBL] [Abstract][Full Text] [Related]
16. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
[TBL] [Abstract][Full Text] [Related]
17. Carbachol activates ERK2 in isolated gastric parietal cells via multiple signaling pathways.
Takeuchi Y; Pausawasdi N; Todisco A
Am J Physiol; 1999 Jun; 276(6):G1484-92. PubMed ID: 10362652
[TBL] [Abstract][Full Text] [Related]
18. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
19. Reversal of the Ras-induced transformed phenotype by HR12, a novel ras farnesylation inhibitor, is mediated by the Mek/Erk pathway.
Reuveni H; Geiger T; Geiger B; Levitzki A
J Cell Biol; 2000 Dec; 151(6):1179-92. PubMed ID: 11121434
[TBL] [Abstract][Full Text] [Related]
20. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
